MedPath

Sun Protection Factor (SPF) / UVA Protection Factor Study

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Other: Day Gel-0120
Other: P5 Reference Standard (SPF 35 reference)
Registration Number
NCT05004168
Lead Sponsor
Indonesia University
Brief Summary

Evaluation of the effectiveness of sunscreen products by determining its Sun Protection Factor (SPF) against UV-B and UV-A

Detailed Description

Sunscreen is intended to protect the skin from sun burn but since the amount of protection needed varies among individuals, sunscreen manufactures offer consumers difference levels of protection. These different levels of protection are expressed as a numerical value called the sun protection factor or SPF. The SPF is the ratio between the minimal erythema dose (MED) of sunscreen product of the protected skin and the MED of the unprotected skin. The minimal erythema dose in human skin is defined as the lowest ultraviolet B (UV-B) dose produces the first perceptible unambigous erythema with defined border appearing over most of the field of UVB exposure 16 - 24 hours after UVB exposure.

The UVA protection factor is the ratio between the Minimal Persistent Pigmentation Darkening Dose (MPPDD) of sunscreen product of the protected skin and the MPPDD of the unprotected skin. The threshold response will be taken as an unequivocal pigment darkening with distinct border which persisted for at least 2 hours.

The test products are Day Gel-0120-C and Day Gel-0120-D with active ingredients ethylhexyl methoxycinnamate, Diethylamino hydroxybenzoyl hexyl benzoate

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SPF evaluationDay Gel-0120Healthy male or female subjects with Fitzpatrick Skin Type of II-IV were included in the SPF study
SPF evaluationP5 Reference Standard (SPF 35 reference)Healthy male or female subjects with Fitzpatrick Skin Type of II-IV were included in the SPF study
Primary Outcome Measures
NameTimeMethod
To measure the SPF Value of the teat product2-24 hours post exposure

The mean of SPF value from all the subject

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Research Supporting Unit

🇮🇩

Jakarta Pusat, DKI Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath